Swiss All Share Index
16.599,85
PKT
-14,32
PKT
-0,09
%
Werbung
Analysen zu Swiss All Share Index-Werten
Datum | Rating | Analyst | |
---|---|---|---|
13.04.06 | UBS | DZ-Bank | |
18.04.06 | Swiss Life kaufen | Nord LB | |
13.04.06 | Swatch (I) | Focus Money | |
11.04.06 | Swiss Life buy | Merrill Lynch | |
11.04.06 | Swiss Life kaufen | Bankhaus Lampe | |
11.04.06 | UBS akkumulieren | Independent Research | |
10.04.06 | UBS halten | Pacific Continental Sec. | |
10.04.06 | Givaudan akkumulieren | Pacific Continental Sec. | |
07.04.06 | UBS | DZ-Bank | |
11.04.06 | Novartis buy | Jyske Bank | |
07.04.06 | Novartis buy | Citigroup | |
06.04.06 | Novartis | Weberbank | |
06.04.06 | UBS | Zürcher Kantonalbank | |
06.04.06 | Schindler | Zürcher Kantonalbank | |
11.04.06 | Holcim halten | Helaba Trust | |
06.04.06 | Novartis buy | UBS | |
05.04.06 | Novartis akkumulieren | Independent Research | |
04.04.06 | Schindler overweight | JP Morgan | |
04.04.06 | Novartis buy | Merrill Lynch | |
04.04.06 | Nestlé buy | Merrill Lynch | |
04.04.06 | Zurich Insurance akkumulieren | Pacific Continental Sec. | |
04.04.06 | Holcim kaufen | Helaba Trust | |
05.04.06 | Swatch (I) buy | Merrill Lynch | |
31.03.06 | UBS | DZ-Bank | |
31.03.06 | Swiss Life kaufen | M.M. Warburg | |
31.03.06 | Novartis | Der Aktionärsbrief | |
31.03.06 | Swiss Life Outperformer | LB Rheinland-Pfalz | |
04.04.06 | Novartis buy | Jyske Bank | |
30.03.06 | Swiss Life hold | WestLB | |
30.03.06 | Swatch (I) | Zürcher Kantonalbank | |
30.03.06 | Holcim verkaufen | Helaba Trust | |
29.03.06 | Novartis buy | Merrill Lynch | |
29.03.06 | Novartis buy | Merrill Lynch | |
29.03.06 | Kühne + Nagel International kaufen | Aktienservice Research | |
28.03.06 | UBS Neutral | JP Morgan | |
27.03.06 | BB Biotech | Wirtschaftswoche | |
28.03.06 | Swiss Life | Volksbank Karlsruhe | |
24.03.06 | UBS | DZ-Bank | |
24.03.06 | Swatch (I) neutral | JP Morgan | |
23.03.06 | Swatch (I) kaufen | National-Bank AG |